Side-by-side comparison of AI visibility scores, market position, and capabilities
"Firebase for healthcare" open-source FHIR EHR API infrastructure; YC S22 $550K with $1.2M revenue serving thousands of health tech developers competing with Google Cloud Healthcare API for HIPAA-compliant infrastructure.
Medplum is a San Francisco-based open-source EHR and healthcare API infrastructure company — often described as "Firebase for healthcare" — providing FHIR-compliant API infrastructure, clinical data management, and workflow tools that healthcare developers use to build EMR-adjacent applications, care management platforms, and health tech products without building from scratch the compliance, data modeling, and interoperability layers that healthcare applications require. Founded in 2021 and backed by Y Combinator (S22) with $550,000 raised, Medplum achieved $1.2 million in revenue in 2024 serving thousands of developers globally building on the open-source platform.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.